ODDB.org: Open Drug Database

Home - 60533 - 02 - 006

Ranexa 500 mg, Retardtabletten - 100 Tablette(n)

Swissmedic Key	60533006	Registration Holder	A. Menarini GmbH
Name	Ranexa 500 mg, Retardtabletten	Date of registration	13.04.2010
		Introduction of Sequence	13.04.2010
ATC-Classification	Ranolazine (C01EB18)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	02.99.	Show package size	100 Tablette(n)
Index Therapeuticus (Swissmedic)	02.99.	Description
Swissmedic categorie.	B
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	75.95	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	99.00
Feedback	FB	Daily cost
GTIN	7680605330066	Medication Code	Synthetika
Pharmacode	4603356	Disponibility

Composition

ranolazinum 500 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 1.54 mg, Überzug: macrogolum 3350, poly(alcohol vinylicus), talcum, cera carnauba, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto.

Packungsbestandteile

Galenic Form

Delayed release tablets

Active Agent	Dose
Ranolazinum	500 mg

BAG: Active Agent	Dose
Ranolazinum	500 mg

Inactive agents	Dose	additional_information
(Flavum)
(Rubrum)
Acidi Methacrylici
Cellulosum Microcristallinum
Cera Carnauba
E 171		color.
E 172		color.
Hypromellosum
Macrogol	3350	Überzug
Magnesii Stearas
Methylis Methacrylatis Polymerisatum
Sodium Hydroxide
Poly(Alcohol Vinylicus)
Pro Compresso Obducto
Talcum

Source

Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH